{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1235, 
        1245
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1285, 
        1308
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1376, 
        1396
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1174, 
        1201
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        681, 
        716
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1125, 
        1151
      ]
    }
  ], 
  "Positive Findings Phraseology (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1222, 
        1234
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 9^9999^MOH|PIMS|CCO|20160502094624|3E18C547BF5DED0B84DE9E9D925F997EA5ACD161|ORU^R01|99999999999999999999|P|2.5|\nPID|1||99999999^^^^CMR^HOSPITAL 9&9999&MOH~99999999^^^^^HOSPITAL 9&9999&MOH~99999999^^^^MRN^HOSPITAL 9&9999~9999999999&AF&ON^^^^JHN||XXXXXX^XXXXX XXXXXXX||99999999|M||E|9999 XXXXXXX XX^^XXXXX^XX^X9X9X9^999||9999999999^AF^OHIN|(613)835-4407X0000||U||7621245914^AF^OHIN||||||||||||N|\nOBR|1||CY1605654|33716-2^Study Report: Cytology.non-gyn^LN^C^Cytology^L|||20160428124500|||58433^XXXXXX^XXXXX^^^^XX||||20160428125249|FNAB of Lung (LLL)|999999^XXXXXX^XXXXX^^^^XX||||N|20082009|20160502094624|||F|||||||99999^XXX^XXXX -X.^^^^XX,XXXXX|\n\n\n\n\n\n\n\nPath report.microscopic observation\n\nThere are tightly cohesive groups of malignant cells present. The cells have medium sized, round to oval nuclei with coarsely granular chromatin, and some have nucleoli. They have a scant amount of cytoplasm.\nTumor cells are reactive for TTF1, non reactive for ck5 or prostatic markers (History of prostatic adenocarcinoma is noted). changes are consistent with a poorly differentiated Lung adenocarcinma\n\n\nPath report.site of origin\n\nFNAB of Lung (LLL)\n\n\nPath report.final diagnosis\n\nFNAB of Lung (LLL)\nPositive for malignancy (Please see microscopic description)\n\n\nPath report.relevant Hx\n\n(Illegible) prostate ca, left lower lobe mass\nFellow: O. Habash\n\n\nPath report.comments\n\nCell block (Formalin fixed): Approximate number of tumour cells in H\\T\\E cell block section(s):\n- 75 tumour cells.\nApproximate % Tumour cellularity (Tumour cells/Total nucleated cells) in H\\T\\E cell block section(s):\n- approximately 15%.\n\n\n"
}